DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Megace (Megestrol) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace (Megestrol) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Uterine Leiomyoma, Gastrooesophageal Reflux Disease, Decreased Appetite, Hypokalaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Dosage: 25 mg (25 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Axitinib (Axitinib)
    Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Axitinib (Axitinib)
    Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Carboplatin
    Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Carboplatin
    Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Paclitaxel
    Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Paclitaxel
    Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625mg/2.5mg (1 in 1 d), oral;
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Celecoxib
    Dosage: 200 mg (200 mg, 1 in 1 d), oral; 200 mg (200 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Megace
    Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Megace
    Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-11-28

Other drugs received by patient: Benadryl; MS Contin; Zofran; Wellbutrin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: female, weighing 65.9 kg (145.0 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 565 mg, every 3 weeks
    Start date: 2011-10-20
    End date: 2011-10-20

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Axitinib
    Dosage: 3 mg, 2x/day, continuously
    Administration route: Oral
    Start date: 2011-11-30

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Carboplatin
    Dosage: 670 mg, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Prempro
    Dosage: 0.625 mg/2.5 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Paclitaxel
    Dosage: 300 mg, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-09-22
    End date: 2011-09-22

Megace
    Dosage: 5cc, 1x/day
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Other drugs received by patient: MS Contin; Benadryl; Wellbutrin; Zofran



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29

Patient: 56 year old female, weighing 84.0 kg (184.8 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Prempro
    Dosage: 1 df: 0.625mg/2.5mg
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Axitinib
    Dosage: from 30nov2011:3mg twice/daily 5mg twicw daily,2 wks on , 1wk off
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Megace
    Dosage: 1 df: 5cc 5ml/day from 28nov11
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Celebrex
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Carboplatin
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Administration route: Oral
    Indication: Menopause
    Start date: 2007-01-01
    End date: 2011-11-01

Paclitaxel
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Other drugs received by patient: MS Contin; Wellbutrin; Benadryl; Zofran



Possible Megace side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: 56 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Prempro
    Dosage: 1 df: 0.625mg/2.5mg
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Paclitaxel
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Axitinib
    Dosage: 3mg twice/daily
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-05

Celebrex
    Administration route: Oral
    Indication: Arthritis
    Start date: 1997-01-01
    End date: 2011-11-01

Metoprolol Tartrate
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Megace
    Dosage: 1 df: 5cc 5ml/day from 28nov11
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Other drugs received by patient: MS Contin; Zofran; Benadryl; Wellbutrin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-08

Patient: female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 5cc, 1x/day
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Prempro
    Dosage: 0.625 mg/2.5 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Axitinib
    Dosage: 3 mg, 2x/day, continuously
    Administration route: Oral
    Start date: 2011-11-30

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Other drugs received by patient: Wellbutrin; Benadryl; Zofran; MS Contin



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: female, weighing 83.8 kg (184.3 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Megace
    Dosage: 5 cc, 1x/day
    Administration route: Oral
    Start date: 2011-11-28

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-06-28

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01
    End date: 2011-11-01

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625 mg/2.5 mg, qd
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral

Megace
    Dosage: 5cc, qd
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Other drugs received by patient: Benadryl; Zofran; Wellbutrin; MS Contin



Possible Megace side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-24

Patient: 56 year old female, weighing 65.9 kg (145.0 pounds)

Reactions: Uterine Leiomyoma, Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoprolol Tartrate
    Dosage: 25 mg (25 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16

Axitinib (Axitinib)
    Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-11-30

Celebrix (Celecoxib)
    Dosage: 200 mg (200 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Prempro
    Dosage: 0.625 mg/2.5 mg (1 in 1 d), oral
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Carboplatin
    Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-20

Paclitaxel
    Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-20
    End date: 2011-10-20

Megace
    Dosage: 5 cc (1 in 1 d), oral
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27

Other drugs received by patient: Benadryl; Wellbutrin; Zofran; MS Contin; Megace; Celebrex



Possible Megace side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22

Patient: female, weighing 65.9 kg (145.0 pounds)

Reactions: Anaemia, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Megace
    Dosage: 5cc, qd
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2011-09-27
    End date: 2011-10-04

Axitinib
    Dosage: 3 mg, 2x/day,1 df
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma

Paclitaxel
    Dosage: 215 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Prempro
    Dosage: 0.625 mg/2.5 mg, qd
    Administration route: Oral
    Indication: Arthritis
    Start date: 2007-01-01

Carboplatin
    Dosage: 565 mg, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-20
    End date: 2011-10-20

Celebrex
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-01-01
    End date: 2011-11-01

Metoprolol Tartrate
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-09-16
    End date: 2011-10-12

Celebrex
    Indication: Arthritis

Megace
    Dosage: 5 ml, 1x/day
    Start date: 2011-11-28

Other drugs received by patient: Wellbutrin; Zofran; Benadryl; MS Contin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017